SarcomaNCT06805773
Evaluating the Use of Educational Videos in Newly Diagnosed Patients in a Medical Oncology Sarcoma Clinic
A study testing Educational videos in people with Sarcoma, run by Mount Sinai Hospital, Canada at 1 site in Canada.
Trial summary
This study aims to evaluate how sarcoma-specific educational videos improve patients' knowledge of their disease and treatment options before their first clinic appointment. Participants will watch four educational videos before their first appointment with a medical oncologist. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Sarcoma
- What is being tested?
- Educational videos
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteCanada
- Study dates
- 5 May 2025to Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Signed written and voluntary informed consent.
- Have histologically documented advanced metastatic sarcoma, or is a caregiver of a patient with histologically documented advanced metastatic sarcoma.
- Age ≥ 18 years.
- Have not received any previous systemic treatment for sarcoma, or is a caregiver of a sarcoma patient who has not received any previous systemic treatment for sarcoma.
- Willing/able to complete questionnaires.
- Able to read and write in English.
Who cannot join
- Inability to provide informed consent.
- Previously seen by a medical oncologist for their sarcoma.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site, 1 recruiting
- Recruiting
Mount Sinai Hospital
Toronto, Ontario, M5G 1X5
Clinical Trials Manager, 4165868440, Oncology.Research@sinaihealth.ca
Geoffrey Watson
About this study
Official title: Evaluating the Use of Educational Videos in a Medical Oncology Sarcoma Clinic to Improve Patient Knowledge and Satisfaction.
This study aims to evaluate how sarcoma-specific educational videos improve patients' knowledge of their disease and treatment options before their first clinic appointment.
Participants will watch four educational videos before their first appointment with a medical oncologist. Participants will be asked to complete surveys to assess their understanding of sarcoma and its treatment options before and after their first medical oncology clinic appointment.
- Conditions
- Sarcoma
- Being tested
- Educational videos, Standard of Care
- Keywords
- Education, Sarcoma
- Medical subject headings
- Sarcoma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Educational videosOther
Participants will be provided with four educational videos in clinic prior to their initial medical oncology consult.
Standard of CareOther
Participants in the control arm will be provided with the educational videos after their consult with the medical oncologist.
| Study group | Role | What they receive |
|---|---|---|
| Educational Videos | Experimental | Not described Receives: Other: Educational videos |
| Standard of Care | Other | Not described Receives: Other: Standard of Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Assess differences in patients' and caregivers' knowledge and perceptions of sarcoma and its treatment before and after educational intervention
Evaluate the changes in global responses between baseline surveys and post educational intervention surveys.
Measured: up to 2 weeks (date when given appointment and date of first appointment)
Secondary outcomes (3)
Assess understandability and actionability of sarcoma educational videos.
The Patient Education Materials Assessment Tool (PEMAT) for Audiovisual Materials will be used to assess the video's understandability and actionability. The higher the score (>80%), the more understandable or actionable the material.
Measured: up to 2 weeks (date when given appointment and date of first appointment)
Assess understandability and actionability of sarcoma educational videos.
The Suitability Assessment of Materials (SAM) will be used for evaluation of health-related information for adults to objectively assess the suitability of these educational materials for sarcoma patients.
Measured: up to 2 weeks (date when given appointment and date of first appointment)
Assess patient's and caregivers' satisfaction with the educational videos
Based on responses from a post-educational intervention survey. The scores will be measured using a Likert Scale (1-5), with higher scores indicating greater satisfaction.
Measured: up to 2 weeks (date when given appointment and date of first appointment)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Feb 2025
- Study start5 May 2025
- Primary completionDec 2027 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for SarcomaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mount Sinai Hospital, Canada
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06805773
- Sponsor's protocol ID
- 4693
- Status last verified
- Oct 2026
- First submitted
- 23 Jan 2025
- Last updated
- 14 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Only IPD used in the results publication will be shared.
Publications
Murtas F, Matharu J, Domlog M, Lawrie K, Salawu A, Gupta A, Deng Y, Avery L, McDonald M, Toor H, Papadakos J, Razak ARA, Watson GA. Evaluating the Feasibility of Educational Videos in a Medical Oncology Sarcoma Clinic to Improve Patient Knowledge and Satisfaction. J Cancer Educ. 2026 Oct 8. doi: 10.1007/s13187-026-03001-0. Online ahead of print.
PubMed 42848271
Study at a glance
From the registry record, last updated by the sponsor on 14 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating the Use of Educational Videos in a Medical Oncology Sarcoma Clinic to Improve Patient Knowledge and Satisfaction.
- ClinicalTrials.gov ID
- NCT06805773
- Acronym / sponsor ID
- 4693
- Conditions
- Sarcoma
- Keywords
- Education, Sarcoma
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Mount Sinai Hospital, CanadaUniversity, hospital or other
- Study start
- 5 May 2025 (actual)
- Primary completion
- Dec 2027 (estimated)
- Study completion
- Dec 2027 (estimated)
- First posted
- 3 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate how sarcoma-specific educational videos improve patients' knowledge of their disease and treatment options before their first clinic appointment.
Participants will watch four educational videos before their first appointment with a medical oncologist. Participants will be asked to complete surveys to assess their understanding of sarcoma and its treatment options before and after their first medical oncology clinic appointment.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Educational Videos | Experimental | Other: Educational videos |
| Standard of Care | Other | Other: Standard of Care |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Signed written and voluntary informed consent.
- Have histologically documented advanced metastatic sarcoma, or is a caregiver of a patient with histologically documented advanced metastatic sarcoma.
- Age ≥ 18 years.
- Have not received any previous systemic treatment for sarcoma, or is a caregiver of a sarcoma patient who has not received any previous systemic treatment for sarcoma.
- Willing/able to complete questionnaires.
Key exclusion criteria (2 listed)
- Inability to provide informed consent.
- Previously seen by a medical oncologist for their sarcoma.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Educational videosParticipants will be provided with four educational videos in clinic prior to their initial medical oncology consult. | Other | Educational Videos |
| Standard of CareParticipants in the control arm will be provided with the educational videos after their consult with the medical oncologist. | Other | Standard of Care |
Primary outcome
Assess differences in patients' and caregivers' knowledge and perceptions of sarcoma and its treatment before and after educational intervention
Time frame: up to 2 weeks (date when given appointment and date of first appointment)
Evaluate the changes in global responses between baseline surveys and post educational intervention surveys.
3 secondary outcomes
Assess understandability and actionability of sarcoma educational videos.
Time frame: up to 2 weeks (date when given appointment and date of first appointment)
Assess understandability and actionability of sarcoma educational videos.
Time frame: up to 2 weeks (date when given appointment and date of first appointment)
Assess patient's and caregivers' satisfaction with the educational videos
Time frame: up to 2 weeks (date when given appointment and date of first appointment)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Oct 2026.
- Derived from this study: PubMed 42848271Murtas F, Matharu J, Domlog M, Lawrie K, Salawu A, Gupta A, Deng Y, Avery L, McDonald M, Toor H, Papadakos J, Razak ARA, Watson GA. Evaluating the Feasibility of Educational Videos in a Medical Oncology Sarcoma Clinic to Improve Patient Knowledge and Satisfaction. J Cancer Educ. 2026 Oct 8. doi: 10.1007/s13187-026-03001-0. Online ahead of print.
- Individual participant dataSharing planned: Yes. Only IPD used in the results publication will be shared.
Related trials for Sarcoma
RecruitingPhase 2
A Multicenter Phase II Clinical Trial Evaluating 68Ga-HX01 Injection for PET/CT Imaging
Soft Tissue Sarcoma
RecruitingPhase 3
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Metastatic Dedifferentiated Liposarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma
RecruitingPhase 2
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma
RecruitingPhase 1/2
Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
Lymphoma, Waldenström Macroglobulinemia (WM)
Enrolling by invitationPhase 1
Evaluation of the I-phase Clinical Trial of 177Lu-HX02 Injection in Patients With Advanced Malignant Solid Tumors
Soft Tissue Sarcoma, Non-small Cell Lung Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Educational videos in people with Sarcoma, run by Mount Sinai Hospital, Canada at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Clinical Trials Manager (416-586-8440, Oncology.Research@sinaihealth.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Assess differences in patients' and caregivers' knowledge and perceptions of sarcoma and its treatment before and after educational intervention (time frame: up to 2 weeks (date when given appointment and date of first appointment)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06805773, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2026.